Business Brief: Mapping a way out
The Bank of Canada is expected to maintain its benchmark lending rate today and for the coming months. An Indian pharmaceutical company has received authorization to sell a generic version of Ozempic, while Barrick Mining Corp. has chosen New York for its upcoming stock listing. Additionally, the UAE's exit from OPEC poses challenges for the oil cartel's pricing power amidst rising oil prices due to geopolitical tensions.
- ▪The Bank of Canada is likely to hold its key lending rate steady at 2.25 percent.
- ▪An Indian pharmaceutical company is the first to be authorized to sell a generic version of Ozempic in Canada.
- ▪Barrick Mining Corp. has selected New York for the primary stock listing of its North American spin-off.
Opening excerpt (first ~120 words) tap to expand
ShareSave for laterPlease log in to bookmark this story.Log InCreate Free AccountGood morning. The Bank of Canada is expected to hold its benchmark lending rate today. For that matter, it’s expected to keep rates steady for the next several months. Today, we’ll look at how the federal government might soon acquire more of the spotlight.Up firstIn the newsMedication: An Indian pharmaceutical company has become the first drug maker authorized to sell a generic version of the blockbuster drug Ozempic, according to Health Canada.Trading: Barrick Mining Corp.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Globe and Mail.
Discussion
0 commentsMore from The Globe and Mail
